Showing results (1-10 of 318) with videos related to
Sort By:
Pageof 32
Frontiers in Endocrinology|December 20, 2021
Current and Potential Therapies Targeting Inflammation in NASHSomaya Albhaisi, Mazen NoureddinClinical and Experimental Medicine|July 9, 2021
The association between serum liver enzymes and cancer mortalitySomaya Albhaisi, Rehan QayyumF1000Research|June 28, 2018
Recent advances in understanding and managing non-alcoholic fatty liver diseaseSomaya Albhaisi, Arun SanyalClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2021
The Value of Medical Registries and Observational Studies Early in Pandemics: The Coronavirus Disease 2019 (COVID-19) ExperienceSomaya Albhaisi, Richard P WenzelFrontiers in Endocrinology|May 27, 2021
Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic SteatohepatitisSomaya Albhaisi, Arun J SanyalPharmaceutical Medicine|January 15, 2020
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DateSomaya Albhaisi, Arun J SanyalJHEP Reports : Innovation in Hepatology|February 11, 2020
Non-alcoholic fatty liver disease in lean individualsSomaya Albhaisi, Abhijit Chowdhury, Arun J SanyalFrontiers in Oncology|September 7, 2023
Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitisSomaya Albhaisi, Jing Sun, Arun J SanyalClinical Liver Disease|August 29, 2022
Treatments for obesity in the context of nonalcoholic steatohepatitis and mental healthAadi Sharma, Somaya Albhaisi, Arun J SanyalHepatology (Baltimore, Md.)|March 19, 2024
MASH clinical trials and drugs pipeline: An impending tsunamiMazen NoureddinPageof 32